CANOPY GROWTH CORP.

Company Overview

Canopy Growth is a world leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with large-scale GMP certified indoor and greenhouse production capacity. All production is held to a high level of quality assurance, procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The company’s core operations are in Canada, the United States, Germany and the United Kingdom, with developing opportunity markets in Australia, Denmark, Peru and Brazil. 

Canopy Growth’s overall strategy is to advance the full potential of cannabis, capture sizeable market share in focus categories and markets and execute a path to profitability to build sustainable, long-term shareholder value. One method for achieving this goal is the continued investment in strategic development agreements, licensing deals and acquisitions. 

The Spectrum Therapeutics medical division is a global leader in medical cannabis. In April 2019, the division acquired Cannabinoid Compound Company, which is currently integrating in to its operations. Cannabinoid Compound Company is Europe’s largest cannabinoid-based pharmaceutical company and a leading manufacturer of dronabinol, a registered active pharmaceutical ingredient in four European countries. 

In June 2019 the company executed an agreement with Acreage, a leading United States multi-state cannabis operator to acquire all the issues and outstanding securities of Acreage upon occurrence of changes in the US federal law to permit the general cultivation, distribution, and possession of marijuana. 

In December 2019, Canopy Growth launched a line of hemp-derived CBD oils and softgels under the First & Free brand in certain U.S. states where not prohibited under state law. 

More recently (September 2020), Canopy Growth introduced its Martha Stewart CBD line of products. The new portfolio includes natural, gourmet flavored wellness gummies, softgels and oil drops derived from Martha Stewart’s renounced specially formulated flavors. The combination of Canopy Growth and Martha Stewart is described by the companies as resulting in pure, safe and great-tasting CBD products that are easy to incorporate into your daily wellness routine.

Financial Highlights (FY 2023)

Company's Business Segments

• Canada cannabis : This includes includes the production, distribution and sale of a diverse range of cannabis, hemp and cannabis-related products in Canada pursuant to the Cannabis Act.
• International markets cannabis : This includes includes the production, distribution and sale of a diverse range of cannabis and hemp products internationally pursuant to applicable international legislation, regulations and permits. Priority markets include medical cannabis in Australia and Europe where the Company offers branded high-quality flower, oil and extract products under our recognized Spectrum Therapeutics and Canopy Medical brands, as well as our Storz & Bickel line of medically approved vaporizers in Australia.
• Storz & Bickel : This comprises the production, distribution and sale of vaporizers and accessories.
• This Works : This comprises the the production, distribution, and sale of beauty, skincare, wellness and sleep products, some of which have been blended with hemp-derived CBD isolate.